|
Cancer Information >> News About Cancer
|
Back
|
|
|
Promising News for Kidney Cancer Patients
|
|
Researchers from the National Cancer Institute (NCI) reported that bevacizumab, a molecularly targeted drug, slowed the growth of tumors in patients with metastatic renal cell carcinoma, the most common form of kidney cancer in adults. Results of the randomized clinical trial were presented at the A |
|
More
|
| |
